• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

周围型胆管癌的西方外科治疗经验

A western surgical experience of peripheral cholangiocarcinoma.

作者信息

Berdah S V, Delpero J R, Garcia S, Hardwigsen J, Le Treut Y P

机构信息

Department of Digestive Surgery and Liver Transplantation, La Conception Hospital, Marseille, France.

出版信息

Br J Surg. 1996 Nov;83(11):1517-21. doi: 10.1002/bjs.1800831108.

DOI:10.1002/bjs.1800831108
PMID:9014664
Abstract

The aim of this retrospective study was to analyse outcome in 31 European patients operated on for peripheral cholangiocarcinoma between 1988 and 1995 (hilar cholangiocarcinoma was excluded). Before 1992, in addition to conventional resection, patients with irresectable tumour and with no extrahepatic metastasis underwent total hepatectomy with liver transplantation. Mild abdominal pain was the most frequent presenting clinical sign (11 of 31 patients) and jaundice was present in only four patients. Preoperative histological findings were available for 20 patients but the diagnosis was correct in only eight of these. Nineteen patients had curative surgery: 17 underwent conventional resection and two had total hepatectomy with liver transplantation. Major hepatectomy was performed in 12 of 17 cases, extended to the caudate lobe in five, to the bile duct confluence in four and to the retrohepatic vena cava in one. Postoperative mortality and morbidity rates were three and seven of 19 patients respectively, median survival was 15 months, and actuarial 1-, 2- and 5-year survival rates were 67, 40 and 32 per cent respectively. Twelve patients had only exploratory laparotomy because of the presence of extrahepatic metastasis or irresectable tumour. The invasive nature of peripheral cholangiocarcinoma can explain the limited number of resectable cases and the particularly unfavourable prognosis. Total hepatectomy does not provide survival benefit. Conventional surgery remains the only effective treatment, even for patients with advanced stage tumours.

摘要

本回顾性研究的目的是分析1988年至1995年间31例接受外周胆管癌手术的欧洲患者的治疗结果(肝门部胆管癌被排除)。1992年以前,除传统切除术外,肿瘤无法切除且无肝外转移的患者接受了肝移植全肝切除术。轻度腹痛是最常见的临床表现(31例患者中有11例),只有4例患者出现黄疸。20例患者有术前组织学检查结果,但其中只有8例诊断正确。19例患者接受了根治性手术:17例行传统切除术,2例行肝移植全肝切除术。17例中有12例进行了大肝切除术,其中5例扩大至尾状叶,4例至胆管汇合处,1例至肝后下腔静脉。19例患者的术后死亡率和发病率分别为3例和7例,中位生存期为15个月,1年、2年和5年的精算生存率分别为67%、40%和32%。12例患者因存在肝外转移或肿瘤无法切除仅接受了剖腹探查术。外周胆管癌的侵袭性可以解释可切除病例数量有限以及预后特别不良的原因。全肝切除术并不能提高生存率。即使对于晚期肿瘤患者,传统手术仍然是唯一有效的治疗方法。

相似文献

1
A western surgical experience of peripheral cholangiocarcinoma.周围型胆管癌的西方外科治疗经验
Br J Surg. 1996 Nov;83(11):1517-21. doi: 10.1002/bjs.1800831108.
2
Surgical treatment of hilar cholangiocarcinoma in the new era: the Asan experience.新时代肝门部胆管癌的外科治疗: 来自首尔峨山医院的经验。
J Hepatobiliary Pancreat Sci. 2010 Jul;17(4):476-89. doi: 10.1007/s00534-009-0204-5. Epub 2009 Oct 23.
3
Peripheral cholangiocarcinoma: presentation, diagnosis, pathology and management.
Eur J Surg Oncol. 1999 Aug;25(4):375-80. doi: 10.1053/ejso.1999.0660.
4
Surgery for hilar cholangiocarcinoma: the Leeds experience.肝门部胆管癌手术:利兹的经验
Eur J Surg Oncol. 2008 Jul;34(7):787-94. doi: 10.1016/j.ejso.2007.10.005. Epub 2007 Nov 26.
5
Outcome after resection of central cholangiocarcinoma: preliminary experience with 46 patients in a single center.
Hepatogastroenterology. 2003 Mar-Apr;50(50):337-41.
6
Changing strategies in diagnosis and management of hilar cholangiocarcinoma.肝门部胆管癌诊断与治疗策略的转变
Liver Transpl. 2000 Nov;6(6):786-94. doi: 10.1053/jlts.2000.18507.
7
[Partial hepatectomy with skeletonization of the hepatoduodenal ligament for hilar cholangiocarcinoma].[肝十二指肠韧带骨骼化的肝门胆管癌根治性肝切除术]
Zhonghua Wai Ke Za Zhi. 2004 Feb 22;42(4):210-2.
8
[Surgical resection with curative intent of hilar cholangiocarcinoma. Our experience].
Acta Gastroenterol Latinoam. 2012 Dec;42(4):291-300.
9
Indications for extended hepatectomy in the management of stage IV hilar cholangiocarcinoma.扩大肝切除术在IV期肝门部胆管癌治疗中的适应证
Arch Surg. 2003 Sep;138(9):1012-6. doi: 10.1001/archsurg.138.9.1012.
10
Aggressive surgical resection for hilar cholangiocarcinoma.肝门部胆管癌的积极手术切除
ANZ J Surg. 2005 Nov;75(11):981-5. doi: 10.1111/j.1445-2197.2005.03595.x.

引用本文的文献

1
Occupational and Environmental Cholangiocarcinoma-Related Toxic Exposures.职业性和环境性与胆管癌相关的有毒暴露
GE Port J Gastroenterol. 2024 Nov 7;32(3):151-160. doi: 10.1159/000541868. eCollection 2025 Jun.
2
Failure patterns after curative resection for intrahepatic cholangiocarcinoma: possible implications for postoperative radiotherapy.肝内胆管细胞癌根治性切除术后的失败模式:对术后放疗的可能影响。
BMC Cancer. 2019 Nov 14;19(1):1108. doi: 10.1186/s12885-019-6328-3.
3
Metformin Induces Apoptosis and Inhibits Proliferation through the AMP-Activated Protein Kinase and Insulin-like Growth Factor 1 Receptor Pathways in the Bile Duct Cancer Cells.
二甲双胍通过AMP激活的蛋白激酶和胰岛素样生长因子1受体途径诱导胆管癌细胞凋亡并抑制其增殖。
J Cancer. 2019 Apr 5;10(7):1734-1744. doi: 10.7150/jca.26380. eCollection 2019.
4
Adjuvant chemotherapy improves oncological outcomes of resectable intrahepatic cholangiocarcinoma: A meta-analysis.辅助化疗可改善可切除性肝内胆管癌的肿瘤学结局:一项荟萃分析。
Medicine (Baltimore). 2019 Feb;98(5):e14013. doi: 10.1097/MD.0000000000014013.
5
Neoadjuvant treatment of biliary tract cancer: state-of-the-art and new perspectives.胆管癌的新辅助治疗:现状与新视角
Hepat Oncol. 2016 Jan;3(1):93-99. doi: 10.2217/hep.15.43. Epub 2015 Nov 30.
6
A New Preoperative Prognostic System Combining CRP and CA199 For Patients with Intrahepatic Cholangiocarcinoma.一种结合CRP和CA199的肝内胆管癌患者术前预后新系统。
Clin Transl Gastroenterol. 2017 Oct 5;8(10):e118. doi: 10.1038/ctg.2017.45.
7
The effect of wide resection margin in patients with intrahepatic cholangiocarcinoma: A single-center experience.肝内胆管癌患者手术切缘宽度的影响:单中心经验
Medicine (Baltimore). 2016 Jul;95(28):e4133. doi: 10.1097/MD.0000000000004133.
8
The elevated preoperative neutrophil-to-lymphocyte ratio predicts poor prognosis in intrahepatic cholangiocarcinoma patients undergoing hepatectomy.术前中性粒细胞与淋巴细胞比值升高预示着接受肝切除术的肝内胆管癌患者预后不良。
Tumour Biol. 2015 Jul;36(7):5283-9. doi: 10.1007/s13277-015-3188-6. Epub 2015 Feb 12.
9
Clinical effect of a positive surgical margin after hepatectomy on survival of patients with intrahepatic cholangiocarcinoma.肝切除术后手术切缘阳性对肝内胆管癌患者生存的临床影响。
Drug Des Devel Ther. 2014 Dec 17;9:163-74. doi: 10.2147/DDDT.S74940. eCollection 2015.
10
Surgical management of proximal bile duct cancers.近端胆管癌的外科治疗。
Langenbecks Arch Surg. 2012 Aug;397(6):869-79. doi: 10.1007/s00423-012-0928-6. Epub 2012 Mar 6.